Adial Pharmaceuticals ADIL

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.00 (+0.00%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Adial Pharmaceuticals (ADIL)
    Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.7499

    • Market Cap

      $4.86 Million

    • Price-Earnings Ratio

      -0.28

    • Total Outstanding Shares

      6.58 Million Shares

    • Total Employees

      7

    • Dividend

      No dividend

    • IPO Date

      July 27, 2018

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      1180 seminole trail, Charlottesville, VA, 22901

    • Homepage

      https://www.adialpharma.com

    Historical Stock Splits

    If you bought 25 shares of ADIL before August 7, 2023, you'd have 1 share today.
    Execution DateSplit Amount
    August 7, 20231-for-25 (Reverse Split)

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Financing Activities$7.85 Million
    Net Cash Flow From Operating Activities, Continuing$-6.92 Million
    Net Cash Flow$0
    Net Cash Flow From Investing Activities$-923,443
    Net Cash Flow From Financing Activities, Continuing$7.85 Million
    Net Cash Flow From Operating Activities$-6.92 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Income/Loss From Continuing Operations Before Tax$-13.20 Million
    Net Income/Loss$-13.20 Million
    Net Income/Loss Attributable To Parent$-13.20 Million
    Nonoperating Income/Loss$-4.91 Million
    Operating Income/Loss$-8.28 Million
    Income/Loss From Continuing Operations After Tax$-13.20 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss$-13.20 Million
    Comprehensive Income/Loss Attributable To Parent$-13.20 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$0

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Current Liabilities$975,858
    Other Non-current Assets$981,830
    Equity Attributable To Noncontrolling Interest$0
    Liabilities$975,858
    Noncurrent Liabilities$0
    Accounts Payable$250,130

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ADIL from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.